비디오 뇌파(Video EEG) 시장 : 시장 예측(2026-2032년)

The Video EEG Market is projected to grow by USD 1,620.27 million at a CAGR of 14.70% by 2032.

Video electroencephalography (video EEG) combines continuous or event-triggered brain-wave recording with synchronized video observation. This enables clinicians to correlate electrical activity with visible behavior, supporting the evaluation of seizures, seizure-like events, altered awareness, sleep-related episodes, and other neurological conditions. Its value is strongest when symptoms are intermittent, difficult to reproduce, or clinically ambiguous.

How Video EEG Is Reshaping Neurological Evaluation

Video EEG is shifting neurological assessment from isolated waveform interpretation toward multimodal, event-centered observation. Improvements in digital recording, electrode systems, bedside monitoring, remote review, and integration with hospital information systems are helping care teams capture, annotate, and compare episodes more efficiently. At the same time, institutions must manage workflow complexity, patient privacy, data storage, artifact reduction, and the need for trained neurophysiology personnel.

Artificial Intelligence Strengthens Detection and Review Workflows

Artificial intelligence can support video EEG by identifying candidate events, prioritizing prolonged recordings for review, reducing repetitive annotation, and combining waveform features with movement or behavioral information. These tools are best treated as decision support rather than autonomous diagnosis because performance can vary across patient populations, recording environments, electrode configurations, and artifact conditions. Responsible adoption requires representative validation, transparent performance reporting, clinician oversight, cybersecurity controls, and clear accountability for final interpretation.

Regional Patterns Across Video EEG Adoption

North America generally benefits from established epilepsy centers, advanced hospital infrastructure, and specialist-led monitoring pathways. Europe combines mature clinical practice with strong data-protection expectations and variation among national health systems. Asia-Pacific includes highly capable specialist markets alongside areas where access to neurophysiology expertise and long-duration monitoring remains uneven. Latin America is shaped by unequal hospital resources, referral concentration, and the importance of solutions that support efficient specialist review. The Middle East is developing advanced tertiary-care capabilities, particularly in major urban centers, while workforce availability and interoperability remain practical considerations. Africa shows substantial need for accessible diagnostic services, with adoption influenced by equipment affordability, reliable connectivity, maintenance capacity, and specialist training.

Group-Level Signals Across Major Economic and Security Blocs

Within ASEAN, differences in healthcare infrastructure and specialist availability make scalable training, mobile services, and interoperable platforms especially relevant. BRICS members reflect varied public and private care models, creating demand for adaptable deployment approaches and locally appropriate clinical protocols. The European Union emphasizes harmonized quality, privacy, and cross-border data governance, while G7 health systems often prioritize evidence-based integration into specialized care pathways. GCC countries can support advanced centralized services but may need sustained workforce development and referral coordination. NATO members span diverse healthcare systems, yet shared interest in resilient digital infrastructure, emergency preparedness, and secure clinical data handling can influence monitoring practices.

Country-Level Considerations for Video EEG Services

Australia and Canada face geographic dispersion that increases the value of tele-neurophysiology and centralized expert review. Brazil, Mexico, India, and South Africa must address uneven access across urban and rural settings while strengthening specialist capacity. China, Japan, and South Korea have substantial hospital and technology capabilities, with continued emphasis on workflow integration, local validation, and aging-related neurological care. France, Germany, Italy, Spain, and the United Kingdom operate established specialist networks but must balance clinical demand, staffing, privacy obligations, and efficient use of monitoring facilities. The United States has broad access to advanced epilepsy services, while maintaining attention to reimbursement structures, data governance, workforce sustainability, and equitable access. Russia's service development is influenced by regional coverage, equipment availability, and continuity of specialist support.

Actions Leaders Can Take to Improve Video EEG Value

Industry leaders should begin with clearly defined clinical use cases and measurable outcomes, such as reduced time to event classification, improved diagnostic confidence, or faster specialist review. They should prioritize interoperable recording and reporting systems, standardized protocols, robust training, and service models that extend expertise to underserved locations. AI investments should proceed through prospective validation, bias monitoring, human-in-the-loop review, and cybersecurity-by-design. Leaders should also establish transparent governance for patient consent, video access, retention, and secondary data use, while partnering with clinicians and patient communities to ensure that operational improvements translate into safer, more equitable care.

Methodology for the Video EEG Executive Summary

This summary uses a structured qualitative assessment of video EEG as a clinical technology and service domain. The analysis considers the relationship between synchronized EEG and video capture, clinical workflow requirements, digital infrastructure, artificial intelligence applications, regulatory and privacy considerations, workforce needs, and access conditions across the specified regions, groups, and countries. Conclusions are framed as evidence-informed operating implications rather than market estimates, forecasts, rankings, or company assessments. Geographic observations reflect broad healthcare-system characteristics and should be validated against local clinical guidelines, procurement rules, reimbursement policies, and facility-level data before implementation.

Conclusion: Building More Connected and Equitable Neurological Monitoring

Video EEG remains an important bridge between physiological measurement and observed clinical behavior. Its greatest practical contribution comes from combining reliable acquisition, expert interpretation, efficient review tools, and well-governed digital workflows. Future progress will depend less on recording capability alone and more on integration: connecting specialists, patients, data systems, and responsible AI while addressing privacy, workforce, infrastructure, and access constraints across diverse healthcare environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Video EEG Market, by Product Type

• 7.1. Introduction
• 7.2. Ambulatory Video EEG
• 7.3. Remote Monitoring
• 7.4. Traditional Video EEG

8. Video EEG Market, by Component

• 8.1. Introduction
• 8.2. Hardware
  • 8.2.1. Amplifier
  • 8.2.2. Eeg System
  • 8.2.3. Electrodes
• 8.3. Services
  • 8.3.1. Installation
  • 8.3.2. Maintenance
  • 8.3.3. Training
• 8.4. Software
  • 8.4.1. Acquisition Software
  • 8.4.2. Analysis Software

9. Video EEG Market, by Modality

• 9.1. Introduction
• 9.2. Inpatient
• 9.3. Outpatient

10. Video EEG Market, by Technology

• 10.1. Introduction
• 10.2. Wired
• 10.3. Wireless

11. Video EEG Market, by Application

• 11.1. Introduction
• 11.2. Epilepsy Monitoring
• 11.3. Neurological Disorders
• 11.4. Sleep Disorders

12. Video EEG Market, by End User

• 12.1. Introduction
• 12.2. Ambulatory Surgical Centers
• 12.3. Homecare Settings
• 12.4. Hospitals & Clinics

13. Video EEG Market, by Region

• 13.1. Introduction
• 13.2. Asia-Pacific
• 13.3. North America
• 13.4. Latin America
• 13.5. Europe
• 13.6. Middle East
• 13.7. Africa

14. Video EEG Market, by Group

• 14.1. Introduction
• 14.2. ASEAN
• 14.3. GCC
• 14.4. European Union
• 14.5. BRICS
• 14.6. G7
• 14.7. NATO

15. Video EEG Market, by Country

• 15.1. Introduction
• 15.2. United States
• 15.3. Canada
• 15.4. Mexico
• 15.5. Brazil
• 15.6. United Kingdom
• 15.7. Germany
• 15.8. France
• 15.9. Russia
• 15.10. Italy
• 15.11. Spain
• 15.12. China
• 15.13. India
• 15.14. Japan
• 15.15. Australia
• 15.16. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. Market Concentration Analysis, 2025
  • 16.2.1. Concentration Ratio (CR)
  • 16.2.2. Herfindahl Hirschman Index (HHI)
• 16.3. Recent Developments & Impact Analysis, 2025
• 16.4. Product Portfolio Analysis, 2025
• 16.5. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Advanced Brain Monitoring, Inc.
• 17.2. Bittium Biosignals Ltd
• 17.3. Brain Products GmbH
• 17.4. Cadwell Laboratories, Inc.
• 17.5. Compumedics Limited
• 17.6. Electrical Geodesics, Inc.
• 17.7. Micromed S.p.A.
• 17.8. Natus Medical Incorporated
• 17.9. Neurosoft Ltd.
• 17.10. Nihon Kohden Corporation

18. Key Experts